Trials / NCT00804102
Transcorneal Electrical Stimulation Therapy for Retinal Disease
Completed N/A Electrical stimulation
- Sponsor
- Okuvision GmbH
- Treatment
- Transcorneal Electrical Stimulation; DTL-electrode attached without energy
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa, Macula Off, Primary Open Angle Glaucoma, Hereditary Macular Degeneration, Treated Retina Detachment, Retinal Artery Occlusion, Retinal Vein Occlusion, Non-Arthritic-Anterior-Ischemic Optic-Neuropathy, Hereditary Autosomal Dominant Optic Atrophy, Dry Age Related Macular Degeneration, Ischemic Macula Edema
- Ages
- 18 Years to no upper limit
- Enrollment
- 80 participants
- Started
- 2008-01
- Main results expected
- 2011-04
- Results posted
- Not yet
- Record last updated
- 2012-05-04
What the study is testing
Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.
Where it runs
No sites listed yet.